Encequidar

gut-restrict. P-gp inh. for oral paclitaxel combo

efficacious in Ph. III, NDA filed but CRL issued

from opt. of tariquidar

J. Med. Chem., Mar. 17, 2021

Athenex / Hanmi Pharmaceutical, Seoul, KR

The Athenex/Hanmi Pharmaceutical P‑gp transporter inhibitor (encequidar) is a gut-restricted compound intended to reduce efflux and increase absorption of the IV drug, paclitaxel to enable oral paclitaxel delivery.  The…


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks